Lymphocytosis

Phase 4 trials (1)

• abatacept

Phase 2 trials (10)

• autologous t cells
• bendamustine
• lenalidomide
• hydroxyurea
• ofatumumab
• ibrutinib
• cyclophosphamide
• vinblastine
• fludarabine
• rituximab

Phase 1 trials (2)

• cyclosporine
• sargramostim

Other trials (3)

• ritonavir
• sitagliptin
• autologous cd34+ cells

Organization Involved with Phase 4 Indications (2)

• Bristol-Myers Squibb
• University of California, Los Angeles

Organization Involved with Phase 2 Indications (6)

• Celgene
• GlaxoSmithKline
• National Cancer Institute (NCI)
• Ohio State University
• Mayo Clinic
• University of Texas at Houston

Organization Involved with Phase 1 Indications (1)

• National Heart, Lung, and Blood Institute (NHLBI)

Organization Involved with Other Experimental Indications (2)

• Columbia University
• City of Hope National Medical Center